Guardant Health Presents Data Demonstrating Utility of Comprehensive Genetic Profiling with Guardant360® Liquid Biopsy Test to Guide Treatment for Advanced Breast Cancer Patients at 2021 San Antonio Breast Cancer Symposium

GuardantINFORM™Â platform offers real-world evidence to identify unmet need for patients with advanced breast cancer December 06, 2021 08:05 AM Eastern Standard Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–sGuardant Health, Inc. (Nasdaq: GH),...

Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015–2020

Bhakti Arondekar, Mei Sheng Duh, Rachel H. Bhak, Maral DerSarkissian, Lynn Huynh, Kelsey Wang, John Wojciehowski, Melody Wu, Bryon Wornson, Alexander Niyazov and George D. DemetriDOI: 10.1158/1078-0432.CCR-21-2639 Article Figures & Data Info & Metrics  PDF Abstract Real-world evidence (RWE) has garnered great interest to support registration of new therapies and label expansions by...